Ki Summary

Reaction Details

Report a problem with these data

Target

Bile acid receptor

Ligand

BDBM50336396

Substrate/Competitor

n/a

Meas. Tech.

ChEMBL_716784 (CHEMBL1670706)

IC50

290±n/a nM

Citation

Richter, HG; Benson, GM; Bleicher, KH; Blum, D; Chaput, E; Clemann, N; Feng, S; Gardes, C; Grether, U; Hartman, P; Kuhn, B; Martin, RE; Plancher, JM; Rudolph, MG; Schuler, F; Taylor, S Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME properties. Bioorg Med Chem Lett21:1134-40 (2011) [PubMed] Article

More Info.:

Get all data from this article, Assay Method

Bile acid receptor

Name:

Bile acid receptor

Synonyms:

BAR | Bile acid receptor FXR | FXR | Farnesol receptor HRR-1 | HRR1 | NR1H4 | NR1H4_HUMAN | Nuclear receptor subfamily 1 group H member 4 | RIP14 | RXR-interacting protein 14 | Retinoid X receptor-interacting protein 14 | farnesoid x receptor

Type:

Nuclear Receptor

Mol. Mass.:

55916.24

Organism:

Homo sapiens (Human)

Description:

Q96RI1

Residue:

486

Sequence:

MVMQFQGLENPIQISPHCSCTPSGFFMEMMSMKPAKGVLTEQVAGPLGQNLEVEPYSQYS
NVQFPQVQPQISSSSYYSNLGFYPQQPEEWYSPGIYELRRMPAETLYQGETEVAEMPVTK
KPRMGASAGRIKGDELCVVCGDRASGYHYNALTCEGCKGFFRRSITKNAVYKCKNGGNCV
MDMYMRRKCQECRLRKCKEMGMLAECMYTGLLTEIQCKSKRLRKNVKQHADQTVNEDSEG
RDLRQVTSTTKSCREKTELTPDQQTLLHFIMDSYNKQRMPQEITNKILKEEFSAEENFLI
LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSD
LLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEK
LQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVNDHKFTPLLC
EIWDVQ

BDBM50336396

n/a

Name

BDBM50336396

Synonyms:

CHEMBL1668262 | trans-4-((2S)-2-(2-(4-chloro-2-methoxypyridin-3-yl)-5,6-difluoro-1H-benzo[d]imidazol-1-yl)-2-cyclohexylacetamido)cyclohexanecarboxylic acid

Type

Small organic molecule

Emp. Form.

C28H31ClF2N4O4

Mol. Mass.

561.02

SMILES

COc1ccc(-c2nc3cc(F)c(F)cc3n2[C@@H](C2CCCCC2)C(=O)N[C@H]2CC[C@@H](CC2)C(O)=O)c(Cl)n1 |r,wU:17.18,27.29,wD:30.36,(29.58,-17.54,;28.81,-16.2,;27.27,-16.19,;26.5,-17.52,;24.95,-17.52,;24.2,-16.19,;22.19,-16.19,;21.71,-14.72,;20.17,-14.72,;19.11,-13.57,;17.63,-13.9,;16.59,-12.76,;17.16,-15.36,;15.65,-15.68,;18.19,-16.51,;19.69,-16.19,;20.95,-17.09,;20.95,-18.65,;22.28,-19.42,;22.28,-20.96,;23.61,-21.73,;24.95,-20.96,;24.95,-19.42,;23.62,-18.65,;19.61,-19.42,;19.61,-20.96,;18.28,-18.65,;16.94,-19.42,;16.94,-20.97,;15.62,-21.73,;14.31,-20.98,;14.31,-19.44,;15.61,-18.66,;12.95,-21.76,;11.63,-21,;12.95,-23.32,;24.96,-14.85,;24.18,-13.5,;26.51,-14.85,)|

Structure